Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Shortage Avoided

BREVICON 0.5/35 TABLETS (28-DAY PACK)

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of BREVICON 0.5/35 TABLETS (28-DAY PACK) in Canada?

Yes. BREVICON 0.5/35 TABLETS (28-DAY PACK) .5MG .035MG has an active shortage reported to Health Canada (last updated May 19, 2026).

Why is BREVICON 0.5/35 TABLETS (28-DAY PACK) not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will BREVICON 0.5/35 TABLETS (28-DAY PACK) be available again?

The manufacturer's estimated resolution date is March 19, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusShortage Avoided
Same-ingredient products on fileNone found
Affected strength.5MG .035MG
Last updated2024-07-31

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02187094

Strength

.5MG .035MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

NORETHINDRONE ETHINYL ESTRADIOL

Tier

Unrated

Last Updated

2024-07-31

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

BREVICON 0.5/35 TABLETS (28-DAY PACK) has 2 shortage/discontinuation reports on file — this is one of them.